Abbott Revenue and Competitors

Chicago, IL USA

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • Abbott's estimated annual revenue is currently $42.3B per year.(i)
  • Abbott's estimated revenue per employee is $192,937
  • Abbott's current valuation is $226.6B. (January 2022)

Employee Data

  • Abbott has 219294 Employees.(i)
  • Abbott grew their employee count by 5% last year.

Abbott's People

NameTitleEmail/Phone
1
Chief ExecutiveReveal Email/Phone
2
Deputy CEOReveal Email/Phone
3
Chairman and CEOReveal Email/Phone
4
Division VP, Controller ElectrophysiologyReveal Email/Phone
5
Divisional VP, Controller Abbott VascularReveal Email/Phone
6
Chief Systems EngineerReveal Email/Phone
7
VPReveal Email/Phone
8
Divisional VP Human Resources, Established PharmaceuticalsReveal Email/Phone
9
Chief ManagerReveal Email/Phone
10
Divisional VP, Reimbursement and Strategic InitiativesReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$3761.3M1871326%N/AN/A
#2
$69340M1126764%N/A$308.4B
#3
$55170M595325%$10.9M$240.2B
#4
$42310M2192945%N/A$226.6B
#5
$18.3M9114%N/AN/A
Add Company

What Is Abbott?

Abbott Laboratories is a global, diversified health care company devoted to the discovery, development, manufacture and marketing of pharmaceuticals, nutritionals and medical products, including devices and diagnostics. The company employs approximately 70,000 people and markets its products in more than 130 countries.

keywords:N/A

N/A

Total Funding

219294

Number of Employees

$42.3B

Revenue (est)

5%

Employee Growth %

$226.6B

Valuation

N/A

Accelerator

Abbott News

2022-04-20 - What's in Store for Abbott Laboratories (ABT) in Q1 Earnings?

Excluding COVID testing sales, Abbott's (ABT) worldwide Diagnostic sales are expected to have demonstrated strong growth in Q1 on the...

2022-04-20 - What's in Store for Abbott Laboratories (ABT) in Q1 Earnings?

Excluding COVID testing sales, Abbott's (ABT) worldwide Diagnostic sales are expected to have demonstrated strong growth in Q1 on the...